Merus N V (MRUS)

Jul 27, 2025

What is the risk reward ratio of investing in Merus N.V. stockCapitalize on market trends early - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What institutional investors are buying Merus N.V. stockBuild a winning investment strategy - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What makes Merus N.V. stock price move sharplyCapitalize on momentum-driven opportunities - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What are Merus N.V. company’s key revenue driversRapid wealth creation - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Should I hold or sell Merus N.V. stock in 2025Massive profits - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Is it the right time to buy Merus N.V. stockMassive profits - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

When is Merus N.V. stock expected to show significant growthHigh-octane investment opportunities await - jammulinksnews.com

Jul 27, 2025

Jul 25, 2025

Merus NV stock reaches all-time high at 66.44 USD - Investing.com

Jul 25, 2025

Jul 25, 2025

Why Merus N.V. stock is on top investor watchlistsHigh-impact stock picks - jammulinksnews.com

Jul 25, 2025

Jul 25, 2025

How high can Merus N.V. stock price go in 2025Breakout stock performance - jammulinksnews.com

Jul 25, 2025

Jul 23, 2025

Merus N.V. Stock Analysis and ForecastGame-changing returns - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

What analysts say about Merus N.V. stockDynamic growth stocks - jammulinksnews.com

Jul 23, 2025

Jul 21, 2025

What drives Merus N.V. stock pricePhenomenal trading returns - Autocar Professional

Jul 21, 2025

Jul 20, 2025

Is Merus N.V. a good long term investmentRapidly expanding wealth - Autocar Professional

Jul 20, 2025

Jul 18, 2025

Merus Shares Soar 3.24% On Positive Cancer Study Update - AInvest

Jul 18, 2025

Jul 18, 2025

Merus NV stock hits all-time high, reaching 62.98 USD - Investing.com

Jul 18, 2025

Jul 17, 2025

Merus Shares Surge Amid Promising Cancer Study - TipRanks

Jul 17, 2025

Jul 17, 2025

Merus N.V. Advances in Head and Neck Cancer Treatment with Phase 3 Study - TipRanks

Jul 17, 2025

Jul 17, 2025

Learn to Evaluate (MRUS) using the Charts - news.stocktradersdaily.com

Jul 17, 2025

Jul 17, 2025

Merus N.V. (NASDAQ:MRUS) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 17, 2025

Jul 16, 2025

Merus N.V. (NASDAQ:MRUS) Given Average Rating of “Buy” by Analysts - Defense World

Jul 16, 2025

Jul 16, 2025

Why Merus N.V. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025

Jul 15, 2025

How Merus N.V. stock performs during market volatilitySwing Trade Signals - newser.com

Jul 15, 2025

Jul 15, 2025

Merus (MRUS) Gets a Buy from H.C. Wainwright - The Globe and Mail

Jul 15, 2025

Jul 14, 2025

Insider Selling: Merus N.V. (NASDAQ:MRUS) COO Sells $924,275.00 in Stock - Defense World

Jul 14, 2025

Jul 12, 2025

Merus (NASDAQ:MRUS) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jul 12, 2025

Jul 11, 2025

MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success - sharewise.com

Jul 11, 2025

Jul 09, 2025

Merus, Bicara Present Promising HNSCC Trial Data at ASCO 2025, Advance Towards Phase III - Insider Monkey

Jul 09, 2025

Jun 29, 2025

Merus N.V. (MRUS): A Breakthrough in Oncology with Petosemtamab's ASCO-Backed Potential - AInvest

Jun 29, 2025

Jun 26, 2025

Merus N.V.’s Promising Phase 3 Study in Head and Neck Cancer: What Investors Need to Know - TipRanks

Jun 26, 2025

Jun 23, 2025

Merus N.V.’s MCLA-129 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Jun 23, 2025

Jun 18, 2025

Merus gains after mid-stage trial data for lead asset in head and neck cancer - MSN

Jun 18, 2025